Syros Pharmaceuticals Inc
(SYRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 09-2015 | 06-2015 | 12-2014 | |
| Sales | 0 | 0 | 317 | 0 |
| Gross Profit | N/A | N/A | 317 | N/A |
| Operating Expenses | 0 | 8,464 | 6,412 | 0 |
| Operating Income | N/A | -8,464 | -6,095 | N/A |
| Other Income | 0 | 0 | -2 | 0 |
| Pre-tax Income | 0 | -8,464 | -6,097 | 0 |
| Net Income Continuous | N/A | -8,464 | -6,097 | N/A |
| Net Income | $N/A | $-8,464 | $-6,097 | $N/A |
| EPS Basic Total Ops | N/A | -45.10 | -41.60 | N/A |
| EPS Basic Continuous Ops | N/A | -39.37 | -34.62 | N/A |
| EPS Diluted Total Ops | N/A | -45.10 | -41.60 | N/A |
| EPS Diluted Continuous Ops | N/A | -39.37 | -34.62 | N/A |
| EBITDA(a) | $N/A | $-8,275 | $-6,095 | $N/A |